Cargando…
Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide
This analysis aimed to investigate whether the long-term administration of temozolomide (TMZ) claimed a survival advantage for patients with glioblastoma in China. A total of 75 patients with newly diagnosed glioblastoma at the Department of Radiation Oncology, Shenzhen People's Hospital betwee...
Autores principales: | Quan, Rencui, Zhang, Huaqing, Li, Zihuang, Li, Xianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959873/ https://www.ncbi.nlm.nih.gov/pubmed/31914038 http://dx.doi.org/10.1097/MD.0000000000018591 |
Ejemplares similares
-
Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017) -
Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
por: Wang, Yu, et al.
Publicado: (2017) -
Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022) -
Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
por: Revilla-Pacheco, Francisco, et al.
Publicado: (2021) -
Characteristics and management of tumor treating fields-related dermatological complications in patients with glioblastoma
por: Yang, Chao, et al.
Publicado: (2023)